Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

Oxford BioTherapeutics: Strategic Collaboration with Roche (2025-03-19)
> Collaboration leverages OBT’s proprietary OGAP®-Verify discovery platform and Roche’s drug development expertise to advance multiple selected novel oncology targets > OBT to receive up to US$36 million upfront payments and may be eligible to receive miles...
[iito] Announces Major Changes in Its Social Media Strategy (2025-03-18)
> [iito] ceased all activities on Twitter/X in 2023 > All social media activities today focussed on LinkedIn > Planning for a future outside of the “big” social media platforms [iito] Business Intelligence – a Germany-based business intelligence p...
Final Close of Sofinnova Biovelocita II Fund at €165m (2025-03-18)
> Biovelocita II attracts robust support from leading pharmaceutical companies, including Amgen, Bristol Myers Squibb, and Pfizer Ventures > The fund has already screened over 300 projects and made several investments into new companies to catalyze transformativ...
BioClec Launches with Backing from Sofinnova Partners (2025-03-18)
> Co-founded by Dr. Marco Colonna, a global expert in neuroimmunology and Alzheimer's research > Led by CEO Gabriella Camboni, an eminent serial entrepreneur with a track record of successful biotech ventures BioClec, a cutting-edge biotechnology company fo...
Recursion Appoints N. Bumpus & E. Sun to Board of Directors (2025-03-18)
Dr. Bumpus brings deep experience in scientific innovation and regulatory strategy, while Elaine Sun adds extensive leadership in life sciences finance and corporate strategy. Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology ...
RegCell Secures $45.8m in Funding; Moves HQ to US (2025-03-18)
> Funding includes $8.5M from an oversubscribed seed financing with up to $37.3M in non-dilutive investment from The Japan Agency for Medical Research and Development (AMED), underscoring Japan’s commitment to breakthrough therapies > Funding will advance RegC...
Sarepta: Young DMD Patient Died after Elevidys Treatment (2025-03-18)
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, shared the following safety update related to ELEVIDYS (delandistrogene moxeparvovec-rokl), the only approved gene therapy in patients with Duchenne muscular dystr...
Latigo Biotherapeutics Closes $150m Series B Led by Blue Owl (2025-03-17)
> Financing led by funds managed by Blue Owl Capital; Senior Managing Director Kevin Raidy joins Latigo’s board > Proceeds support advancement of company’s Nav1.8 inhibitor clinical programs and development of broader pipeline Latigo Biotherapeutics (�...
Taiho to Acquire Araris Biotech AG for up to $1.14b (2025-03-17)
Taiho Pharmaceutical Co., Ltd. (hereinafter "Taiho Pharmaceutical") and Araris Biotech AG (hereinafter "Araris"), a Swiss biotechnology company developing next-generation antibody drug conjugates (ADCs), announced today that they have entered into a definitive agre...
Samsung Invests $10m in C2N Diagnostics (2025-03-13)
C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a $10 million USD investment from Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis, and Samsung Venture Investment Corp...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

» Start here with the latest News!

Picture Swiss Biotech Association LSUS Swiss Biotech Days 2025 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]